Top Markets
Coin of the day
Poniard Pharmaceuticals, Inc. Poniard Pharmaceuticals, Inc.

Poniard Pharmaceuticals, Inc.

PARD
Hisse Senetlerindeki Sıralama #42765
Poniard Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to the... Poniard Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to the discovery and market introduction of cancer treatments. Its flagship product candidate, Picoplatin, is a platinum-based therapy targeting various cancer types, such as small cell lung, colorectal, prostate, and ovarian cancers. The company has advanced Picoplatin through several clinical stages, including a pivotal Phase III SPEAR trial for small cell lung cancer patients in a second-line treatment setting. Furthermore, Phase II studies investigated Picoplatin as an initial therapy for metastatic colorectal cancer and hormone-refractory prostate cancer. An early-stage Phase I trial also examined an oral formulation of Picoplatin for solid tumors. Founded in 1984 as NeoRx Corporation, the company rebranded to Poniard Pharmaceuticals, Inc. in September 2006 and operates from its base in Seattle, Washington.
Hisse Fiyatı
$0.0001
Son senkronizasyon: 2026-08-11
Piyasa Değeri
$150.00
Değişim (1 gün)
0.00%
Değişim (1 yıl)
0.00%
Ülke
US
Ticaret Poniard Pharmaceuticals, Inc. (PARD)

Kategori

B piyasa değeri ile PARD fiyatı
Poniard Pharmaceuticals, Inc. Poniard Pharmaceuticals, Inc.
PARD
$0.0001
Piyasa Değeri Poniard Pharmaceuticals, Inc.(PARD)
Piyasa Değeri: $150.00
August 2026 itibarıyla Poniard Pharmaceuticals, Inc. şirketinin piyasa değeri $150.00. Bu, verilerimize göre Poniard Pharmaceuticals, Inc. şirketini dünyanın en değerli 42765th. şirketi yapar. Piyasa değeri, halka açık bir şirketin tedavüldeki hisse senetlerinin toplam piyasa değeri olup, bir şirketin değerini ölçmek için yaygın olarak kullanılır.
Poniard Pharmaceuticals, Inc. piyasa değeri geçmişi (1988 - 2026)
En Popüler 5 stocks ile karşılaştırıldığında PARD
PARD’in Fiyatı B Varlığı B’nin Piyasa Değeri Sonuçlar
Poniard Pharmaceuticals, Inc. Poniard Pharmaceuticals, Inc.
$3,617,326 $150.00
$5.426T +3,617,325,682,222.00%
Poniard Pharmaceuticals, Inc. Poniard Pharmaceuticals, Inc.
$2,951,277 $150.00
$4.427T +2,951,277,314,540.00%
Poniard Pharmaceuticals, Inc. Poniard Pharmaceuticals, Inc.
$2,759,300 $150.00
$4.139T +2,759,299,687,403.33%
Poniard Pharmaceuticals, Inc. Poniard Pharmaceuticals, Inc.
$2,437,362 $150.00
$3.656T +2,437,362,459,384.67%
Poniard Pharmaceuticals, Inc. Poniard Pharmaceuticals, Inc.
$1,923,764 $150.00
$2.886T +1,923,763,906,900.00%